ArticleTrials2020

Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.

Helene Haeberle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.